A new study out of Israel finds that a booster shot of the Pfizer COVID-19 vaccine was effective in preventing infections in older people. Some independent scientists say only older adults may need booster shots, and not the general population. (The New York Times)

United Airlines says 95% of its management, and 90% of all employees, have been fully vaccinated before its Sept. 27 deadline. The company announced a vaccine mandate last month. (Reuters)

Amgen’s combination treatment of KRAS-blocking drug Lumakras and targeted cancer drug Vectibix resulted in improved tumor response rates, a new study shows. The combination therapy aims to treat advanced colon cancer. (STAT)

Emergent BioSolutions has made a $90 million deal with Providence Therapeutics to provide drug development and manufacturing services for mRNA vaccines. Providence is currently testing a vaccine candidate in Phase II trials. (Endpoints News)

The use of “teledermatology” – or virtual dermatology – has increased during the COVID-19 pandemic. It’s helped dermatologists learn how to best use technology in their clinical practice. (Business Insider)